Korea Investment Partners

Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company specializes in a health technology platform that utilizes laser-based imaging technology to enhance the diagnosis and treatment of cardiovascular diseases. Raywatt's offerings include optical coherence tomography (OCT)-based machine learning for fractional flow reserve (FFR) prediction, as well as catheter-based high-speed OCT imaging. These advanced imaging technologies provide healthcare professionals with high-speed and high-resolution tools to improve patient outcomes in the field of cardiology.

Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company specializes in a health technology platform that utilizes laser-based imaging technology to enhance the diagnosis and treatment of cardiovascular diseases. Raywatt's offerings include optical coherence tomography (OCT)-based machine learning for fractional flow reserve (FFR) prediction, as well as catheter-based high-speed OCT imaging. These advanced imaging technologies provide healthcare professionals with high-speed and high-resolution tools to improve patient outcomes in the field of cardiology.

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases, and pursues therapeutic diagnostic technologies to enable microbiome-focused treatments. The company’s platform supports safe gastrointestinal microbiota transplant in a medical setting, formulates fecal microbiota transplant capsules for oral administration, and conducts research and development of bacteriophages, with the aim of delivering convenient, economical therapies that reduce infection risk. Through these approaches, MicrobiotiX seeks to advance microbiome and phage therapies for difficult-to-treat conditions, integrating diagnostics with therapeutics to streamline patient care.

Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

Syntekabio, Inc. is a bioinformatics company based in Daejeon, South Korea, founded in 2009. The firm specializes in genome analysis and the integration of bio data, utilizing advanced algorithms to create personal genome maps that facilitate disease prevention and the development of customized medications. Syntekabio also offers a technology for collecting and integrating decrypted whole genome data, which is instrumental in analyzing diseases, including rare conditions. Their MAHA supercomputer significantly reduces data-processing costs and enhances genome-based diagnostics. The company focuses on gene-related research and technology development, leveraging a genome big data platform and artificial intelligence for drug development and genetic analysis.

DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.

BioM ATS intends to provide the fundamental infrastructure required to progress the complex strain design platform and foster technical collaboration with microbiome firms through proof-of-concept (POC) of the complex strain design technology. It is a strategy to begin the platform business in earnest by the end of the year, with an emphasis on platform advancement and collaboration with industry, academia, research institutes, and the military.

Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

Atoplex is a home test system and diagnosis platform using molecular immunodiagnosis technology.

CashWalk is a fitness tracking app that helps user to track their fitness activity by providing data and analytics from the past.

Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.

Otus is a healthcare institute that specializes in advanced eyecare system.

Haoxinqing is an online medical service platform that specializes in mental psychology and chronic disease management. The company offers remote diagnosis and treatment services, allowing patients to access medical care conveniently from their homes. By focusing on these areas, Haoxinqing aims to enhance patient experience and improve health outcomes, making it easier for individuals to manage their mental health and chronic conditions effectively.

Sky Labs is a technology company focused on developing innovative wearable devices for health monitoring, particularly a cuffless ring-type blood pressure monitor and a device known as the Cardio Tracker (CART). The CART is designed for continuous monitoring of atrial fibrillation, a common and often undiagnosed heart condition affecting many individuals over 40. This device can be worn comfortably on any finger and is both waterproof and dustproof, allowing users to wear it throughout their daily activities without interruption. It operates without user intervention, automatically detecting and recording atrial fibrillation, which users can track via a smartphone application. The device aims not only to assist individuals in managing their heart health but also to provide valuable data to healthcare professionals for accurate diagnosis. Sky Labs is currently conducting clinical trials in collaboration with Seoul National University Hospital to validate the performance of its technology, with an initial focus on the atrial fibrillation patient market in Finland, and an extended target market of millions worldwide. The company is also partnering with Bayer to explore further healthcare innovations.

Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.

Founded in 2016, Humanscape specializes in blockchain-based health data platforms. It collects comprehensive patient health data, including genotype, clinical, and phenotype information, to facilitate drug discovery and improve treatments for intractable and rare diseases.

Trost Company, established in 2016 and headquartered in Seoul, South Korea, specializes in mental healthcare services. The company offers an array of online counseling options, including an employee assistance program (EAP) designed to support organizations in promoting mental well-being among employees. Utilizing a mobile application named TROST, the company connects users with qualified counselors who provide diagnosis and treatment through virtual consultations. Additionally, Trost offers various self-analysis tests, covering areas such as psychological health, personality assessment, depression, self-esteem, and job-related stress. Through its services, Trost aims to enhance access to mental health resources and foster psychological well-being.

Geninus is a biotechnology company specializing in clinical genome analysis solutions tailored for precision medicine clinics. By leveraging advanced genomic technologies, Geninus aims to enhance the accuracy and effectiveness of personalized medical treatments. The company focuses on delivering innovative tools and insights that facilitate the interpretation of genetic data, ultimately supporting healthcare providers in making informed decisions for patient care. Through its services, Geninus contributes to the evolving landscape of precision medicine, promoting better health outcomes through individualized approaches to treatment.

Haoxinqing is an online medical service platform that specializes in mental psychology and chronic disease management. The company offers remote diagnosis and treatment services, allowing patients to access medical care conveniently from their homes. By focusing on these areas, Haoxinqing aims to enhance patient experience and improve health outcomes, making it easier for individuals to manage their mental health and chronic conditions effectively.

Medizen Humancare, founded in 2012 and headquartered in Seoul, South Korea, is a research company specializing in genomic analysis to predict individual disease risks. The company offers services such as M-CHECK, which analyzes patients' genetic risk for specific diseases using gene chips or analysis kits, and MELTHY (DTC), a DNA analysis service. Medizen Humancare's work involves acquiring disease-specific genome contents, identifying new drug candidate genes, and developing preventive measures, with a focus on guiding disease prevention and extending healthy life spans through personalized genetic insights.

Founded in 2016, Humanscape specializes in blockchain-based health data platforms. It collects comprehensive patient health data, including genotype, clinical, and phenotype information, to facilitate drug discovery and improve treatments for intractable and rare diseases.

PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, established in 2016. The company connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its innovative communication platform. Users can engage with medical professionals via video calls, voice calls, and chat, allowing for real-time consultations and health advice. Additionally, HaloDoc facilitates the ordering of laboratory tests that can be conducted at home, enhancing the convenience of accessing healthcare services. The platform aims to simplify and improve the healthcare experience for patients by providing easy connections to doctors, clinics, and hospitals, as well as offering medical delivery services through its partner pharmacies.

Founded in 2011, Gencurix is a South Korean company specializing in the development of molecular diagnostic products to support precision medicine. Its portfolio includes prognostic tests for breast cancer (GenesWell BCT) and lung cancer (GenesWell ddEGFR Mutation Test), as well as companion diagnostics for lung cancer.

Founded in 2014, I.M.Lab specializes in manufacturing innovative cardiopulmonary resuscitation (CPR) training kits. Its flagship product, cprCUBE, is a sensor-based CPR training aid that assists users in learning chest compressions effectively. The company also offers HeartiSense kit for real-time data tracking and HeartiSense LMS for managing training data. I.M.Lab's products cater primarily to medical test and training institutions.

Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

Olive Healthcare is a company specializing in digital healthcare and medical diagnostic devices. It focuses on abdominal fat scanning and breast cancer diagnosis by utilizing non-radiative and non-invasive near infrared (NIR) technology. The company employs artificial intelligence algorithms and big data processing to deliver customized medical services. Olive Healthcare's devices not only measure abdominal fat but also offer personalized exercise and diet guidance based on individual health metrics. By providing these tailored services, the company aims to assist users in reducing belly fat and mitigating the risk of metabolic diseases.

Otus is a healthcare institute that specializes in advanced eyecare system.

EuBiologics Co., Ltd., established in 2010 and based in Seoul, South Korea, is a biopharmaceutical company specializing in the development and supply of vaccines for epidemic prevention and antibiotic resistance. Its product portfolio includes Euvchol, an oral cholera prevention vaccine, and CRM197, a diphtheria toxin mutant vaccine. The company also offers customized services for mammalian and microbial cell-derived biopharmaceuticals, supporting clients from cell line development to GMP production, along with regulatory support. Additionally, EuBiologics provides contract testing services, process and formulation development, and licensing consulting services, contributing to human health across various stages of life.